Regenxbio Inc (Inactive Symbol)

YTD Price Probability

No random walk data for 2024

Default prediction by Z-Score (what's this?).

Z Score :

26.4137

Sector

Industry

View the other companies in the same industry : Bio Therapeutic Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:

Z' Score :

18.5263

Sector Industry

For non-manufacturing companies:

Z'' Score :

47.8018

Sector Industry

Fundamental Analysis metrics & ratios (what's this?).

Date of financial statements used: 2017-03-31
Book Value:	$212.9M	Internal Value:	$212.9M	Working Capital:	$138.8M
Debt to Asset Ratio:	0.050	Current Ratio:	14.940	Turnover Ratio:	N/A
Net Margin:	-4780.4%	EPS:	-3.323	P/E ratio:	-5.567
P/B ratio:	2.300	ROE:	-41.3%	ROA:	-39.2%

Symbol: RGNX

Market Cap: $489.7M

Exchange: NASDAQ

Data Since: 2016-01-04